Wegovy (semaglutide) has been heralded as a revolutionary new weight loss drug, in this video I share everything you need to know about this GLP-1 receptor agonist (Saxenda / Ozempic alternative); how it works, the pros, cons and side effects.

We are coming to understand more and more about how obesity is a complex, chronic disease with multifactorial causes, so it is too simplistic to think that one medication may solve our obesity problems, but I am pleased that it is acknowledging the metabolic disturbance associated with obesity. Ultimately, we need change on a societal level, but this is not a bad start for those seeking to improve their health and lose weight!

Please note, I state that patients lost on average '12% body fat' compared to placebo, but actually it is 'body weight'.

Published 19th February 2023. Due to be reviewed April.

References:
https://www.nice.org.uk/news/article/nice-recommends-new-drug-for-people-living-with-obesity